Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential merits of trialling CAR T Cell Therapy for the treatment of Mesothelioma.
The Department funds and supports research into health and care research through the National Institute for Health Research (NIHR). The NIHR is supporting the delivery of the study ‘Immunotherapy for malignant mesothelioma using ErbB re-targeted Chimeric Antigen Receptor (CAR) T-cells in combination with checkpoint inhibition’ funded by the Asthma UK and British Lung Foundation Partnership.